Trends in survival outcomes among patients relapsing early after autologous stem cell transplantation for multiple myeloma.
Study #: MM14-03
Study Status: Published
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, Kharfan-Dabaja M, Freytes C, Hashmi S, Hildebrandt G, Holmberg L, Kyle R, Lazarus H, Lee C, Mikhael J, Nishihori T, Tay J, Usmani S, Vesole D, Vij R, Wirk B, Krishnan A, Gasparetto C, Mark T, Nieto Y, Hari P, D'Souza A.
Leukemia. 2018, Apr 01: 32(4): 32(4):986-995. doi: 10.1038/leu.2017.331. Epub 2017, Nov 16. PMCID:PMC5871538.
PMID: 29263438
Abstract